What cough suppressants and antibiotics are safe for use in a pregnant woman?

Safe Cough Medications and Antibiotics for Pregnant Women

For cough suppression in pregnancy, codeine and dextromethorphan are recommended for short-term symptomatic relief, while for bacterial infections requiring antibiotics, amoxicillin, cephalosporins (like cefuroxime), and azithromycin are considered compatible or probably safe throughout pregnancy. 1

Cough Suppressants

First-Line Options

• Codeine: Recommended for chronic bronchitis with fair evidence and substantial benefit 2. Classified as compatible during pregnancy based on the ERS/TSANZ guidelines framework 1. Short-term use is acceptable 3.

• Dextromethorphan: Also recommended for chronic bronchitis with similar evidence quality 2. While the 2006 ACCP guidelines support its use, specific pregnancy safety data should be considered alongside codeine.

Important Caveats

• Ipratropium bromide (inhaled anticholinergic) is recommended specifically for cough due to upper respiratory infections or bronchitis, with substantial benefit 2
• Avoid agents that alter mucus characteristics—these show no benefit for cough suppression 2
• Most over-the-counter cold medications contain multiple ingredients; pregnant women should read labels carefully to avoid unnecessary medications 4

Antibiotics in Pregnancy

Compatible/First-Line Antibiotics

Beta-lactams (Category A/B1):

• Amoxicillin: Category A—compatible throughout pregnancy 1

  • Caveat: Very low risk of oral clefts during organogenesis 1

• Amoxicillin-clavulanic acid: Category B1—compatible 1

  • Important warning: NOT recommended in women at risk of preterm delivery due to very low risk of necrotizing enterocolitis in the fetus 1

• Cefuroxime: Category B1—compatible. Human data indicate no teratogenic effects at therapeutic doses 1

Macrolides:

• Azithromycin: Category B1—probably safe 1

  • Breastfeeding note: Very low risk of hypertrophic pyloric stenosis in infants during first 13 days of breastfeeding (not after 2 weeks) 1

• Clarithromycin: Category B3—probably safe, though produced adverse outcomes in animal studies; human data suggest low risk 1

Second-Line Options (Use When First-Line Fails)

• Ciprofloxacin: Category B3—possibly safe. Most clinicians try to avoid during pregnancy, but if a fluoroquinolone is indicated, ciprofloxacin should be chosen over alternatives 1

Antibiotics to Avoid or Use with Extreme Caution

• Co-trimoxazole (sulfamethoxazole-trimethoprim): Category C—avoid in first trimester; possibly safe in second/third trimester with folic acid supplementation. Associated with neonatal hyperbilirubinemia and fetal hemolytic anemia at delivery 1

• Tetracyclines: Should be avoided unless maternal necessity justifies fetal exposure 5

• Quinolones (except ciprofloxacin when necessary): Generally avoided due to potential fetal cartilage damage in animal studies 6

Inhaled Antibiotics (for specific conditions like cystic fibrosis)

• Tobramycin (inhaled): Compatible—minimal systemic absorption makes it minimal risk despite systemic category D 1
• Colistimethate sodium (inhaled): Category B2/C—probably safe with minimal absorption 1
• Aztreonam (inhaled): Category B1 1

Clinical Decision Algorithm

For cough:

1. Identify cause (URI vs. chronic bronchitis)
2. If URI: Consider ipratropium bromide inhaled
3. If chronic bronchitis: Use codeine or dextromethorphan for short-term relief
4. Avoid combination products with multiple unnecessary ingredients

For bacterial infections:

1. First choice: Amoxicillin or cefuroxime (unless specific contraindications)
2. If penicillin allergy: Azithromycin
3. If first-line fails: Consider clarithromycin or ciprofloxacin based on infection type
4. Avoid in first trimester: Co-trimoxazole
5. Never use if at risk for preterm delivery: Amoxicillin-clavulanic acid

Key Principles

The overarching principle from the ERS/TSANZ guidelines is that the risk of untreated maternal disease (including severe cough or bacterial infection with potential maternal hypoxia) often poses greater fetal risk than appropriate medication use 1. Short-term use of evidence-based medications at the lowest effective dose is the standard approach 3.

Human data spanning decades support the safety of penicillins, cephalosporins, and erythromycins in pregnancy 5. The 2025 antibiotic safety review reinforces that clinicians must balance maternal necessity against fetal risk, with most common antibiotics having acceptable safety profiles when used appropriately 7.